The Only Complete Online Marketing Firm
Sunday, May 31, 2015
ASCO: Triple Agent Tx Thwarts CLL Progress
(MedPage Today) -- Ibrutinib plus chemo and immunotherapy outplays standard treatment.
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment